Dependence of KCC2 K-Cl cotransporter activity on a conserved
carboxy terminus tyrosine residue
Kevin
Strange,
Thomas D.
Singer,
Rebecca
Morrison, and
Eric
Delpire
Anesthesiology Research Division, Laboratories of Cellular and
Molecular Physiology, Departments of Anesthesiology and
Pharmacology, Vanderbilt University Medical Center, Nashville,
Tennessee 37232
 |
ABSTRACT |
K-Cl cotransporters (KCC) play
fundamental roles in ionic and osmotic homeostasis. To date, four
mammalian KCC genes have been identified. KCC2 is expressed exclusively
in neurons. Injection of Xenopus oocytes with KCC2
cRNA induced a 20-fold increase in Cl
-dependent,
furosemide-sensitive K+ uptake. Oocyte swelling increased
KCC2 activity 2-3 fold. A canonical tyrosine phosphorylation
site is located in the carboxy termini of KCC2 (R1081-Y1087) and
KCC4, but not in other KCC isoforms. Pharmacological studies, however,
revealed no regulatory role for phosphorylation of KCC2 tyrosine
residues. Replacement of Y1087 with aspartate or arginine dramatically
reduced K+ uptake under isotonic and hypotonic conditions.
Normal or near-normal cotransporter activity was observed when Y1087
was mutated to phenylalanine, alanine, or isoleucine. A tyrosine
residue equivalent to Y1087 is conserved in all identified KCCs from
nematodes to humans. Mutation of the Y1087 congener in KCC1 to
aspartate also dramatically inhibited cotransporter activity. Taken
together, these results suggest that replacement of Y1087 and its
congeners with charged residues disrupts the conformational state of
the carboxy terminus. We postulate that the carboxy terminus plays an
essential role in maintaining the functional conformation of KCC
cotransporters and/or is involved in essential regulatory protein-protein interactions.
neurons; potassium transport; cation-coupled chloride cotransport; cell volume regulation; furosemide
 |
INTRODUCTION |
THE
POTASSIUM-CHLORIDE cotransporter plays fundamental roles in
intracellular and extracellular ionic and osmotic homeostasis (4, 13, 14, 16,
20, 24). Extensive studies carried out on red
blood cells have defined the basic properties of this transport
pathway (4, 14). The cotransporter mediates
electroneutral, obligatorily coupled, transmembrane K+ and
Cl
movements. Potassium chloride flux is driven by the
sum of the chemical potential differences for K+ and
Cl
. Under normal physiological conditions, the K-Cl
cotransporter functions as a solute efflux pathway driven by the
outwardly directed chemical gradient for K+. The
cotransporter is activated by cell swelling and plays an important role
in cell volume regulation.
Gillen et al. (8) were the first to report the cloning of
the K-Cl cotransporter protein, KCC1. Sequence analysis demonstrated that KCC1 is a member of the cation-chloride cotransporter
(CCC) superfamily that includes the Na-K-2Cl cotransporter (NKCC1 and NKCC2) and the thiazide-sensitive Na-Cl cotransporter (NCC). The functional characteristics of heterologously expressed KCC1 resemble those of the K-Cl cotransporter in red cells and include activation by
cell swelling and N-ethylmaleimide (NEM). KCC1 is expressed in numerous tissues, suggesting that it may be a "housekeeping" isoform responsible for cell volume regulation (8).
Three other K-Cl cotransporter isoforms have been cloned recently
(8, 9, 17, 21).
KCC3 is found predominantly in the heart, skeletal muscle, brain, and
kidney (9, 17, 23). KCC4 is
expressed widely; the most abundant expression is observed in heart and
kidney (17).1 Both KCC3 and KCC4
are activated by cell swelling in heterologous expression systems
(17, 23).
KCC2 is found only in neurons (20, 21,
24). Expression of this transporter varies during neuronal
development (16, 24). Developmental
regulation of KCC2 and the Na-K-2Cl cotransporter NKCC1
(22) appears to function critically in regulation of
neuronal Cl
concentration. The concentration of
Cl
in neurons has significant impact on GABAergic
neuronal signaling and information processing (3,
24), which in turn may play an important role in neuronal
development and synapse formation (7, 15,
19).
In addition to intracellular Cl
regulation, Payne
(20) has proposed that KCC2 may function to regulate
extracellular K+ concentration in the brain. During
neuronal activity, extracellular K+ levels rise and must be
tightly controlled to maintain normal neuronal function
(18). Payne (20) has suggested that under certain conditions, KCC2 may function as a KCl influx pathway, thereby
reducing extracellular K+ levels.
The signaling mechanisms that regulate K-Cl cotransport are
incompletely understood. Serine/threonine protein phosphatase inhibitors inhibit K-Cl cotransporter activity (2,
11, 26), whereas inhibition of protein kinase
activity with NEM (12) or staurosporine (1)
activates the transport pathway. The tyrosine kinase inhibitor
genistein inhibits the effects of both NEM and staurosporine
(6). In red cell ghosts, volume-sensitive K-Cl cotransport
is increased by vanadate, a tyrosine phosphatase inhibitor, and
decreased by genistein (25). K-Cl cotransport activity is substantially elevated in red cells from knockout mice deficient in the
Fgr and Hck Src family tyrosine kinases (5). These
findings indicate that both serine/threonine and tyrosine
phosphorylation play important roles in KCC regulation. However, the
identities of the phosphorylation substrate proteins are unknown.
The postulated physiological roles of KCC2 in the central nervous
system underscore the importance of defining how the transporter is
regulated. A canonical tyrosine kinase motif is located in the carboxy
terminus of KCC2. This motif is also present in KCC4 but not in any of
the other identified K-Cl cotransporters isoforms, suggesting that KCC2
and KCC4 may be uniquely regulated by direct tyrosine phosphorylation.
To test this possibility, we developed KCC2 expression assays using
cRNA-injected Xenopus oocytes and transiently transfected
Chinese hamster ovary (CHO) cells. We demonstrate here that tyrosine
phosphorylation events do not appear to be important for regulating
KCC2 activity in heterologous expression systems. However, mutation of
the tyrosine residue in the kinase motif dramatically alters
transporter function. We suggest that this tyrosine residue, which is
conserved in all identified KCC isoforms, may participate in regulatory
protein-protein interactions and/or be responsible for maintaining the
active conformational state of the cotransporter.
 |
MATERIAL AND METHODS |
Expression of K-Cl cotransporters in Xenopus oocytes.
cDNA clones for rat KCC2 (rtKCC2) and rabbit KCC1 (rbKCC1) were
generous gifts from Drs. John Payne (University of California, Davis)
and Bliss Forbush (Yale University), respectively. The open reading
frames of both clones were subcloned into the oocyte expression vector
pBF (kindly provided by Dr. Bernd Falker, University of Tubingen).
Linearized template DNA was transcribed in vitro by Sp6 RNA polymerase
using a mMessage mMachine kit (Ambion, Austin, TX). Capped cRNA was
precipitated in ethanol and resuspended in RNase-free H2O.
Stage V and VI oocytes from Xenopus laevis were manually
defolicullated and maintained in modified L-15 medium (Life
Technologies, Gaithersburg, MD) diluted to an osmolality of 195 mosmol/kgH2O. One day after isolation, oocytes were
microinjected with 50 nl of H2O or 50 nl of cRNA solutions.
In preliminary studies, oocytes were injected with 1-100 ng of
cRNA coding for rtKCC2. The highest levels of cotransporter activity
were observed 3-4 days after injection. Optimal expression was
observed with injection of 27.5 ng of cRNA. Injection of larger amounts
of cRNA reduced transport activity. Given these results, all additional
studies were carried out using oocytes injected with 27.5 ng cRNA.
Functional studies were performed 3 days after injection.
Transient transfection of Chinese hamster ovary cells.
For transient transfections, KCC2 was subcloned into pcDNA3
(Invitrogen, Carlsbad, CA). Stock cultures of Chinese hamster ovary
(CHO-K1) cells were grown at 37°C and 5% CO2
in Ham's F12 medium containing 10% fetal bovine serum (Hyclone,
Logan, UT). For transfection, cells were seeded at ~70% confluence
into 6-well culture dishes. After 24 h, cells were rinsed briefly
with OptiMEM (Life Technologies), and the culture medium in each well
was replaced with 1 ml of OptiMEM containing 1 µg DNA and 15 µg
Lipofectamine (Life Technologies). After incubation for 5.5 h in a
37°C incubator, the DNA/Lipofectamine medium was replaced with Ham's
F-12 medium. This medium was changed after 24 h, and cells were
allowed to grow for another 24 h before fluxes were performed.
86Rb+ uptake assays.
To prevent 86Rb uptake via the endogenous Na-K-Cl
cotransporter and Na+-K+-ATPase, all uptake
measurements in oocytes were performed using a Na+-free
flux medium containing 1 mM ouabain. The flux medium contained 48 mM
choline chloride, 3.5 mM KCl, 1.8 mM CaCl2, 1.0 mM
MgCl2, and 5 mM HEPES (pH 7.4, 195 mosmol/kgH2O). Medium osmolality was adjusted by
addition or removal of sucrose. Chloride removal studies were performed
by replacing Cl
with NO3
.
Oocytes were washed three times with flux medium and then transferred
to individual wells of a six-well culture plate. Oocytes were incubated
at room temperature in 300 µl of flux medium containing 25 µCi/ml
86Rb. Uptake was terminated by washing oocytes five times
in ice-cold flux medium. 86Rb content was determined by
liquid scintillation counting after digestion of individual oocytes in
200 µl of 0.1 N NaOH. Preliminary studies demonstrated that
86Rb uptake was linear for at least 1 h. All flux
measurements were therefore performed using a 1 h uptake period.
86Rb uptake measurements on transiently transfected CHO
cells were performed using a Na+-free flux medium
containing 140 mM N-methyl-D-glucamine
(NMDG)-Cl, 5 mM KCl, 1.2 mM MgCl2, 2 mM CaCl2,
10 mM HEPES, and 0.5 mM ouabain (pH 7.4, 295 mosmol/kgH2O). Chloride removal studies were
carried out by replacing NMDG-Cl with NMDG-NO3, KCl and
MgCl2 with K2SO4 and
MgSO4, and CaCl2 with calcium digluconate.
Cells were washed three times with 2 ml of flux medium and then
incubated with 2 ml of flux medium at room temperature. After 15 min,
the medium was replaced with 2 ml of flux medium containing 5 µCi/ml
86Rb and incubated for 10 min. Uptake was terminated by
washing cells three times in ice-cold flux medium. 86Rb
content was determined by liquid scintillation counting after digestion
of cells in 2 ml of 0.1 N NaOH. Preliminary studies demonstrated that
86Rb uptake was linear for at least 30 min. For both oocyte
and CHO cell flux measurements, it was assumed that Rb+ was
a congener of K+. All flux data are therefore expressed as
rates of K+ uptake.
Mutagenesis.
Single amino acid mutations were generated using a QuickChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA). All mutations
were verified by automated DNA sequencing.
Immunolocalization.
Oocytes were embedded in Tissue-Tek OCT compound (Sakura Finetek,
Torrance, CA), frozen, and sectioned by cryostat into 5-µm thick
sections. Sections were fixed in ice-cold 100% acetone for 3 min and
then washed four times for 5 min each in PBS containing 0.05%
Tween 20. After washing, sections were treated with blocking solution
(1% BSA and 4% goat serum in PBS) for 30 min and then incubated
overnight at 4°C with purified polyclonal KCC2 antibodies (16). Antibody-treated sections were then washed four
times for 5 min each in PBS/0.05% Tween 20, incubated for 30 min with blocking solution, treated for 1 h with a Cy3-conjugated mouse anti-rabbit secondary antibody, and washed in PBS/0.05% Tween 20.
Immunofluorescence was visualized using a Nikon Eclipse E800 equipped
with a Nikon Plan Apo ×100 objective lens (1.4 NA) and an Optronics
DEI-750 color charge-coupled device camera (Optronics Engineering,
Goleta, CA). Montages were generated from digitized images using Adobe
Photoshop 4.0 and printed with a Tektronix Phaser 450 color printer
(Tektronix, Wilsonwill, OR). Immunolocalization of KCC2 was performed
in parallel in oocytes injected with either wild-type or mutant
cotransporter cRNA. Images were acquired using identical camera
settings to determine semi-quantitatively whether mutagenesis altered
KCC2 trafficking.
Chemicals.
Tyrosine kinase and phosphatase inhibitors were purchased from
Calbiochem (La Jolla, CA) and Biomol (Plymouth Meeting, PA). Pervanadate was prepared fresh before each experiment by mixing 1 part
500 mM H2O2 with 50 parts of 10 mM
Na3VO4.
Statistical analysis.
Data are presented as means ± SE. Statistical significance was
determined using Student's two-tailed t-test for unpaired, independent means. When comparing three or more groups, statistical significance was determined by one-way analysis of variance using the
Tukey-Kramer Multiple Comparisons Test. P
0.05 was
taken to indicate statistical significance.
 |
RESULTS AND DISCUSSION |
Functional characterization of KCC2 expressed in Xenopus oocytes.
Figure 1A illustrates the
basic properties of KCC2 expressed in oocytes. Injection of KCC2 cRNA
increased Na+-independent K+ uptake nearly
20-fold compared with oocytes injected with water. Exposure to 1 mM NEM
increased K+ uptake in KCC2 oocytes ~35%
(P < 0.02). Both basal and NEM-stimulated K+ flux were inhibited 60-80% (P < 0.0001) by 2 mM furosemide. Swelling oocytes by exposure to a 100 mosmol/kgH2O bath solution increased K+ uptake ~2.5-fold (P < 0.0001).
Replacement of Cl
with NO3
or exposure
to 2 mM furosemide inhibited K+ uptake in hypotonic medium
80-90% (P < 0.0001).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Basic characteristics of rat KCC2 (rtKCC2) expressed in
Xenopus oocytes. A: KCC2 expression increases
K+ uptake ~20 fold compared with water-injected control
oocytes. N-ethylmaleimide (NEM) and oocyte swelling
significantly increase K+ uptake. Potassium flux is
inhibited 60-90% by 2 mM furosemide or Cl removal.
NEM and furosemide were present throughout the 1 h uptake period.
Values are means ± SE (n = 9-22 oocytes).
B: the serine/threonine phosphatase inhibitor calyculin A
inhibits basal and swelling-induced KCC2 activity. Oocytes were exposed
to calyculin A throughout the 1-h uptake period. Values are means ± SE (n = 11-14 oocytes).
|
|
Native K-Cl cotransport activity is inhibited by the serine/threonine
protein phosphatase inhibitors calyculin A and okadaic acid, indicating
that phosphorylation regulates cotransporter function (2,
11, 26). As shown in Fig. 1B, 1 µM calyculin A inhibited both basal and swelling-induced
K+ uptake in KCC2-injected oocytes by 65-70%
(P < 0.0008).
Basal KCC2 activity is inhibited by cell shrinkage (Figs. 1B
and 2). Calyculin A had no significant
(P > 0.5) effect on K+ uptake in
KCC2-expressing oocytes exposed to hypertonic (270 mosmol/kgH2O) medium (Fig. 1B).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Osmotic sensitivity of K+ uptake in oocytes
expressing rat KCC2 or rabbit KCC1 (rbKCC1). Both KCC1 and KCC2 are
activated by oocyte swelling. Basal KCC2 activity is inhibited by
hypertonic medium. Values are means ± SE (n = 10-18 oocytes). *P < 0.05 compared with uptake
measured in water-injected oocytes bathed in 195 mosmol/kgH2O bath medium.
|
|
The effects of furosemide, NEM, calyculin A, and Cl
removal are signature characteristics of K-Cl cotransport
(8, 14) and demonstrate that KCC2 is
functionally expressed in oocytes. The inhibitory effect of calyculin A
demonstrates that serine/threonine phosphorylation events regulate KCC2
activity. NEM and swelling also increased significantly
(P < 0.0001, Fig. 1A) furosemide-sensitive and Cl
-dependent K+ uptake in water-injected
oocytes, suggesting the presence of an endogenous component of K-Cl
cotransport activity.
Payne (20) has demonstrated that cell swelling has no
effect on KCC2 activity when the transporter is expressed in HEK-293 cells. One possibility for the discrepancy in our results and those of
Payne (20) is the difference in the magnitude of hypotonic shocks used in the two studies. KCC2-transfected HEK cells were exposed
to an ~20% reduction in bath osmolality (20).
Experiments illustrated in Fig. 1 utilized an ~50% hypotonic shock.
The differences in degree of hypotonicity suggest that KCC2 might
require larger increases in volume for activation. We therefore
examined the volume sensitivity of KCC2 in more detail and compared it
to KCC1, a ubiquitous K-Cl cotransporter isoform shown previously to be swelling activated (8).
Figure 2 shows the relationship between bath osmolality and
K+ uptake in water-injected control oocytes and oocytes
expressing KCC2 or KCC1. KCC1 activity under basal conditions (i.e.,
195 mosmol/kgH2O) was not significantly different
(P > 0.8) from control oocytes. Reduction of bath
osmolality to 165, 130, or 100 mosmol/kgH2O increased
K+ uptake 413%, 568%, and 561%, respectively.
In contrast to KCC1, K+ uptake under basal conditions in
KCC2-injected oocytes was ~10-fold higher than water-injected
controls. Hypertonicity inhibited basal uptake ~50%. Exposure to
hypotonic bath solutions of 165, 130, or 100 mosmol/kgH2O
increased K+ uptake 240%, 335%, and 332%, respectively.
These results indicate that the overall osmotic responsiveness of
K+ uptake in KCC1- and KCC2-injected oocytes is similar.
However, the degree of swelling-induced stimulation of KCC1 is
substantially higher than that of the KCC2 cotransporter.
Interestingly, we have observed that swelling has no effect on
KCC2-mediated K+ uptake when the cotransporter is
transiently or permanently transfected into Chinese hamster ovary (CHO)
cells (data not shown), a finding in agreement with those of Payne
(20). Data shown in Figs. 1-2 demonstrate clearly
that the KCC2 cotransporter possesses the molecular features necessary
for swelling-induced activation. The difference in KCC2 volume
sensitivity observed in various heterologous expression systems may be
due to differences in the proteins that regulate the cotransporter. For
example, in Xenopus oocytes, there may be "promiscuous"
interactions between KCC2 and regulatory proteins, such as the putative
volume-sensitive kinase (11) thought to play a role in
swelling-induced signal transduction. Alternatively, regulatory
proteins responsible for KCC2 volume sensitivity that are present in
Xenopus oocytes may not be expressed in HEK-293 and CHO cells.
Regulatory role of a carboxy terminal tyrosine residue.
As discussed in the Introduction, tyrosine phosphorylation has been
implicated in the regulation of K-Cl cotransport (5, 6, 25). The carboxy terminus of KCC2 contains
a canonical tyrosine kinase phosphorylation site at R1081-Y1087
(17, 21). To examine the possible role of
this site in tyrosine phosphorylation-dependent regulation of KCC2, we
replaced Y1087 with aspartate (Y1087D) to mimic phosphorylation (e.g.,
Ref. 28). As shown in Fig. 3, this mutation reduced K+ uptake under isotonic conditions
70-80% and completely inhibited swelling-induced KCC2 activation
(P < 0.0001 compared with wild type). Hypertonicity
inhibited K+ uptake 41% in oocytes expressing wild-type
KCC2 (P < 0.0001). A similar degree of inhibition
(42.5%, P < 0.002 compared with wild type) was seen
with the Y1087D mutant. Replacement of Y1087 with phenylalanine
(Y1087F), which differs from tyrosine by a single hydroxyl group,
restored normal basal and swelling-induced cotransporter activity.
Hypertonicity inhibited K+ uptake 38% (P < 0.0001) in Y1087F-expressing oocytes.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of mutation of Y1087 on KCC2 activity. Mutation of
Y1087 to aspartate (Y1087D) inhibits basal transport activity
70-80% and completely prevents swelling-induced KCC2 activation.
Normal KCC2 activity is observed when Y1087 is replaced with
phenylalanine (Y1087F). Values are means ± SE (n = 10-19 oocytes).
|
|
The dramatic reduction in transport activity of the Y1087D mutant
suggested that it may not be trafficked to the membrane properly. To
address this issue, we immunolocalized KCC2. As shown in Fig.
4, immunofluorescence levels were
qualitatively similar in the plasma membranes of oocytes expressing
wild-type or Y1087D KCC2. These results indicate that the Y1087D mutant
is trafficked normally to the cell surface.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
The Y1087D KCC2 mutant is trafficked normally to the
plasma membrane. KCC2 was immunolocalized using anti-KCC2 purified
polyclonal antibodies and a Cy3-labeled secondary antibody in
water-injected (H2O) oocytes and in oocytes expressing
wild-type (WT) KCC2 or the Y1087D mutant.
|
|
To examine further the role of tyrosine phosphorylation in KCC2
regulation, we treated oocytes with 100 µM dephostatin, a broadly
selective tyrosine phosphatase inhibitor (27). As shown in
Fig. 5, dephostatin had no significant
(P > 0.05) effect on basal KCC2 cotransport activity.
However, swelling-induced cotransporter activation was inhibited
(P < 0.05) nearly completely by the drug.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of the tyrosine phosphatase inhibitor dephostatin
on basal (isotonic, Iso) and swelling-induced (hypotonic, Hypo)
cotransporter activity in oocytes expressing wild-type or Y1087F KCC2.
Oocytes were incubated with 100 µM dephostatin for 20 min prior to
performing flux measurements and throughout the 1-h uptake period.
Values are means ± SE (n = 36-56 oocytes).
|
|
The inhibitory effect of dephostatin could be due to changes in the
activity of tyrosine phosphatases that directly alter the cotransporter
phosphorylation state. Alternatively, dephostatin may
indirectly alter KCC2 function by disrupting the activity of other
signaling and/or regulatory pathways. To test for this possibility, we
examined the effects of dephostatin on the Y1087F mutant. As observed
with wild-type KCC2, the drug had no effect on basal transport
activity. However, swelling-induced cotransporter activity was
inhibited ~30% (P < 0.003, Fig. 5).
The inhibitory effect of dephostatin on swelling-induced K+
uptake in oocytes expressing the Y1087F mutant implies that direct phosphorylation of Y1087 does not downregulate KCC2 cotransporter activity. Instead, these findings are more consistent with those of De
Franceschi et al. (5). These investigators proposed that tyrosine phosphorylation mediated by Fgr and Hck tyrosine kinase activity negatively regulates serine/threonine protein phosphatase 1 (PP-1). Increased phosphorylation of substrate proteins brought about
by inhibition of PP-1 leads to reduced cotransport activity. Inhibition
of tyrosine phosphatase activity by dephostatin could have a similar
negative regulatory effect on PP-1, thereby reducing KCC2 function.
The results obtained using oocytes treated with dephostatin were
extremely variable. For example, in one experiment we observed that
dephostatin completely inhibited swelling-induced activation of the
Y1087F mutant, whereas in two other experiments it had little or no effect.
In our hands, we have observed that certain types of pharmacological
experiments in oocytes are often difficult to reproduce and interpret.
We therefore developed a KCC2 flux assay using CHO cells. As shown in
Fig. 6A, transient
transfection of CHO cells with KCC2 cDNA increased K+
uptake approximately threefold (P < 0.001).
Replacement of Cl
with NO3
or
application of 2 mM furosemide completely inhibited K+
uptake in KCC2-expressing cells (P < 0.001) but had no
inhibitory effect (P > 0.05) on mock transfected
cells. These studies demonstrate clearly that 1) CHO cells
do not normally express Cl
-dependent and
furosemide-sensitive K+ transport and 2) that
transient transfection with KCC2 cDNA induces robust K-Cl cotransporter
activity.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Functional properties of KCC2 transiently expressed in
Chinese hamster ovary (CHO) cells. A: transient transfection
of CHO cells with KCC2 cDNA induces Cl -dependent and
furosemide (Furo)-sensitive K+ uptake. CHO cells were
transiently transfected with KCC2 cDNA or empty vector (mock
transfection). Potassium uptake was measured over a 10-min period in
Na+-free medium containing 0.5 mM ouabain. In
Cl -free medium, Cl was replaced with
NO3 . Values are means ± SE (n = 6-11). B: effects of tyrosine phosphatase and kinase
inhibitors on K+ uptake in CHO cells transfected with KCC2
cDNA. Results are presented as rates relative to those observed in mock
transfected cells treated with the same agents. Cells were exposed to
the drugs during the 15-min equilibration period and throughout the
10-min uptake period. No significant (P > 0.05)
inhibitory effect was observed for any of the drugs tested. Dephostatin
appeared to induce a small but significant (P < 0.001)
stimulation of K+ uptake. Values are means ± SE
(n = 4-12).
|
|
We tested the effects of tyrosine phosphatase (dephostatin and
pervanadate) and kinase (genistein) inhibitors on KCC2-mediated K+ uptake in transiently transfected cells. As shown in
Fig. 6B, 50 µM dephostatin, 100 µM pervanadate, or 100 µM genistein had no significant (P > 0.05)
inhibitory effect on K+ uptake. Taken together with results
obtained in Xenopus oocytes (Fig. 5), these findings
indicate that tyrosine phosphorylation of the KCC2 protein does not
play an important role in regulating its activity.
Y1087, as well as a number of other amino acid residues located in the
carboxy terminus of KCC2, are conserved in all of the identified
mammalian and nonmammalian K-Cl cotransporters (8-10, 17, 21) (Fig.
7). This conservation of primary
structure indicates that the carboxy terminus likely plays an important
regulatory role in KCC function.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Carboxy terminal amino acid sequences for representative
mammalian K-Cl cotransporters (rat KCC1, rat KCC2, human KCC3 and mouse
KCC4; GenBank accession numbers U55053, U55816, AF105366, and AF08436,
respectively) and C. elegans (CE) KCC(1) and
KCC(2) cotransporters (GenBank accession numbers U40798
and U23171, respectively). Amino acid sequences that are identical or
have highly conserved substitutions in all 6 cotransporters are
highlighted in yellow and green shading, respectively. The conserved
tyrosine residue located at position 1056 in KCC1 and 1087 in KCC2 is
further highlighted by the red box. Gaps are added to obtain best
alignment. Alignments were performed using AlignX from VectorNTI 5 Suite (Informax, North Bethesda, MD).
|
|
The unambiguous inhibitory effect of the Y1087D mutation (Fig. 3),
coupled with the conservation of the equivalent tyrosine residue in all
identified KCC isoforms and across widely divergent species (Fig. 7),
suggested that this amino acid plays a key functional role in K-Cl
cotransport. To test this hypothesis, we mutated the equivalent
tyrosine residue, Y1056, to aspartate in KCC1. Mutant and wild-type
KCC1 were expressed in Xenopus oocytes. As shown in Fig.
8, the Y1056D mutation completely
inhibited swelling-induced activation of KCC1 (P < 0.001). When Y1056 was replaced with phenylalanine, swelling-induced
activation of KCC1 was observed, albeit at a rate ~50% lower
(P < 0.001) than that of the wild-type transporter. As
with the Y1087D form of KCC2, we observed by immunofluorescence that
the Y1056D KCC1 mutant appeared to be trafficked to the cell surface
normally (data not shown).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of mutation of Y1056 on KCC1 activity. Mutation of
Y1056 to aspartate (Y1056D) completely inhibits swelling-induced KCC1
activation. Replacement of Y1056 with phenylalanine (Y1056F) partially
restores KCC1 function. Values are means ± SE (n = 10-14 oocytes).
|
|
On the basis of the data shown in Figs. 5, 6, and 8, we conclude that
1) KCC2 Y1087 does not regulate cotransporter activity by
functioning as a site for regulatory tyrosine phosphorylation and
2) that this conserved residue (see Fig. 7) plays an
important functional role in all identified KCC isoforms. Given this
conclusion, it was of interest to determine the functional consequences
of other amino acid substitutions at Y1087. As shown in Table
1, near-normal K+ uptake is
observed in oocytes injected with KCC2 mutants in which Y1087 was
substituted with amino acids possessing either short (alanine) or long
(isoleucine) aliphatic side chains. These results are similar to those
observed when tyrosine is substituted with the aromatic side chain
amino acid phenylalanine (Figs. 3 and 8). However, replacement of
tyrosine with the positively charged arginine caused nearly complete
loss of cotransporter activity under both basal and swelling conditions
similar to that of aspartate (Figs. 3 and 8). These results indicate
that the presence of a charged residue at Y1087 disrupts the
conformation of the carboxy terminus and/or protein-protein
interactions that are essential for normal cotransporter activity.
Conclusions.
In summary, our studies have identified a conserved tyrosine residue
located in the carboxy terminus of K-Cl cotransporters that plays an
important role in normal cotransporter function. Mutation of this
tyrosine to charged residues dramatically inhibits cotransporter
activity. We postulate that this conserved tyrosine residue, as well as
other highly conserved amino acids in the carboxy termini of all
identified K-Cl cotransporters (see Fig. 7), are required to maintain
the active conformational state of the proteins and/or that they
function as sites for essential regulatory protein-protein interactions.
 |
ACKNOWLEDGEMENTS |
This work was supported by National Institutes of Health Grants
NS-30591 (to K. Strange) and NS-36758 (to E. Delpire). E. Delpire is an
Established Investigator of the American Heart Association. Thomas
Singer was supported by a Postdoctoral Fellowship from the Natural
Sciences and Engineering Research Council of Canada.
 |
FOOTNOTES |
Address for reprint requests and other correspondence: K. Strange, Dept. of Anesthesiology Research Division, Vanderbilt Univ. Medical Center, T-4202 Medical Center North, Nashville, TN 37232-2520 (E-mail: kevin.strange{at}mcmail.vanderbilt.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact. 1 Note that in deference
to an earlier publication (9), Mount and coworkers
(17) reversed the numbering of their KCC3 and KCC4 clones.
KCC3 is now referred to as KCC4 and vice versa.
Received 12 November 1999; accepted in final form 29 March 2000.
 |
REFERENCES |
1.
Bize, I,
and
Dunham PB.
Staurosporine, a protein kinase inhibitor, activates K-Cl cotransport in LK sheep erythrocytes.
Am J Physiol Cell Physiol
266:
C759-C770,
1994[Abstract/Free Full Text].
2.
Bize, I,
Guvenc B,
Robb A,
Buchbinder G,
and
Brugnara C.
Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes.
Am J Physiol Cell Physiol
277:
C926-C936,
1999[Abstract/Free Full Text].
3.
Cherubini, E,
Gaiarsa JL,
and
Ben-Ari Y.
GABA: an excitatory transmitter in early postnatal life.
Trends Neurosci
14:
515-519,
1991[ISI][Medline].
4.
Cossins, AR,
and
Gibson JS.
Volume-sensitive transport systems and volume homeostasis in vertebrate red blood cells.
J Exp Biol
200:
343-352,
1997[Abstract/Free Full Text].
5.
De Franceschi, L,
Fumagalli L,
Olivieri O,
Corrocher R,
Lowell CA,
and
Berton G.
Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport.
J Clin Invest
99:
220-227,
1997[Abstract/Free Full Text].
6.
Flatman, PW,
Adragna NC,
and
Lauf PK.
Role of protein kinases in regulating sheep erythrocyte K-Cl cotransport.
Am J Physiol Cell Physiol
271:
C255-C263,
1996[Abstract/Free Full Text].
7.
Gaiarsa, JL,
McLean H,
Congar P,
Leinekugel X,
Khazipov R,
Tseeb V,
and
Ben-Ari Y.
Postnatal maturation of gamma-aminobutyric acid A and B-mediated inhibition in the CA3 hippocampal region of the rat.
J Neurobiol
26:
339-349,
1995[ISI][Medline].
8.
Gillen, CM,
Brill S,
Payne JA,
and
Forbush B.
Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family.
J Biol Chem
271:
16237-16244,
1996[Abstract/Free Full Text].
9.
Hiki, K,
D'Andrea RJ,
Furze J,
Crawford J,
Woollatt E,
Sutherland GR,
Vadas MA,
and
Gamble JR.
Cloning, characterization, and chromosomal location of a novel human K+-Cl
cotransporter.
J Biol Chem
274:
10661-10667,
1999[Abstract/Free Full Text].
10.
Holtzman, EJ,
Kumar S,
Faaland CA,
Warner F,
Logue PJ,
Erickson SJ,
Ricken G,
Waldman J,
and
Dunham PB.
Cloning, characterization, and gene organization of K-Cl cotransporter from pig and human kidney and C. elegans.
Am J Physiol Renal Physiol
275:
F550-F564,
1998[Abstract/Free Full Text].
11.
Jennings, ML,
and
al-Rohil N.
Kinetics of activation and inactivation of swelling-stimulated K+/Cl
transport. The volume-sensitive parameter is the rate constant for inactivation.
J Gen Physiol
95:
1021-1040,
1990[Abstract].
12.
Jennings, ML,
and
Schulz RK.
Okadaic acid inhibition of KCl cotransport. Evidence that protein dephosphorylation is necessary for activation of transport by either cell swelling or N-ethylmaleimide.
J Gen Physiol
97:
799-817,
1991[Abstract].
13.
Kelley, SJ,
and
Dunham PB.
Mechanism of swelling activation of K-Cl cotransport in inside-out vesicles of LK sheep erythrocyte membranes.
Am J Physiol Cell Physiol
270:
C1122-C1130,
1996[Abstract/Free Full Text].
14.
Lauf, PK,
Bauer J,
Adragna NC,
Fujise H,
Zade-Oppen AMM,
Ryu KH,
and
Delpire E.
Erythrocyte K-Cl cotransport: properties and regulation.
Am J Physiol Cell Physiol
263:
C917-C932,
1992[Abstract/Free Full Text].
15.
LoTurco, JJ,
Owens DF,
Heath MJS,
Davis MBE,
and
Kriegstein AR.
GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis.
Neuron
15:
1287-1298,
1995[ISI][Medline].
16.
Lu, J,
Karadsheh M,
and
Delpire E.
Developmental regulation of the neuronal-specific isoform of the K-Cl cotransporter, KCC2, in postnatal rat brains.
J Neurobiol
39:
558-568,
1999[ISI][Medline].
17.
Mount, DB,
Mercado A,
Song L,
Xu J,
George A,
Delpire E,
and
Gamba G.
Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family.
J Biol Chem
274:
16355-16362,
1999[Abstract/Free Full Text].
18.
Newman, EA.
Glial cell regulation of extracellular potassium.
In: Neuroglia, edited by Kettenmann H,
and Ransom BR.. New York: Oxford University, 1995, p. 717-731.
19.
Obrietan, K,
and
van den Pol AN.
GABA activity mediating cytosolic Ca2+ rises in developing neurons is modulated by cAMP-dependent signal transduction.
J Neurosci
17:
4785-4799,
1997[Abstract/Free Full Text].
20.
Payne, JA.
Functional characterization of the neuronal-specific K-Cl cotransporter: implications for [K+]o regulation.
Am J Physiol Cell Physiol
273:
C1516-C1525,
1997[Abstract/Free Full Text].
21.
Payne, JA,
Stevenson TJ,
and
Donaldson LF.
Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform.
J Biol Chem
271:
16245-16252,
1996[Abstract/Free Full Text].
22.
Plotkin, MD,
Snyder EY,
Hebert SC,
and
Delpire E.
Expression of the Na-K-2Cl cotransporter is developmentally regulated in postnatal rat brains: a possible mechanism underlying GABA's excitatory role in immature brain.
J Neurobiol
33:
781-795,
1997[ISI][Medline].
23.
Race, JE,
Makhlouf FN,
Logue PJ,
Wilson FH,
Dunham PB,
and
Holtzman EJ.
Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter.
Am J Physiol Cell Physiol
277:
C1210-C1219,
1999[Abstract/Free Full Text].
24.
Rivera, C,
Voipio J,
Payne JA,
Ruusuvuori E,
Lahtinen H,
Lamsa K,
Pirvola U,
Saarma M,
and
Kaila K.
The K+/Cl
co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation.
Nature
397:
251-255,
1999[ISI][Medline].
25.
Sachs, JR,
and
Martin DW.
The role of ATP in swelling-stimulated K-Cl cotransport in human red cell ghosts. Phosphorylation-dephosphorylation events are not involved in the signal transduction pathway.
J Gen Physiol
102:
551-573,
1993[Abstract].
26.
Starke, LC,
and
Jennings ML.
K-Cl cotransport in rabbit red cells: further evidence for regulation by protein phosphatase type 1.
Am J Physiol Cell Physiol
264:
C118-C124,
1993[Abstract/Free Full Text].
27.
Voets, T,
Manolopoulos V,
Eggermont J,
Ellory C,
Droogmans G,
and
Nilius B.
Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins.
J Physiol (Lond)
506:
341-352,
1998[Abstract/Free Full Text].
28.
Wu, Y,
Spencer SD,
and
Lasky LA.
Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein.
J Biol Chem
273:
5765-5770,
1998[Abstract/Free Full Text].
Am J Physiol Cell Physiol 279(3):C860-C867
0363-6143/00 $5.00
Copyright © 2000 the American Physiological Society